a comparative evaluation of intranasal dexmedetomidine vs midazolam for preoperative sedation in children

A Comparative Evaluation Of Intranasal Dexmedetomidine & Intranasal Midazolam For Premedication In Children A Double Blind Randomised Control Trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/04/013123

Enrollment

Registered

2018-04-09

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- All children belonging to ASA 1 health status

Interventions

Intervention1: dexmedetomidine injection: 100 mcg/ml Intervention2: dexmedetomidine: 100 mcg/ml vials used. drug was diluted to desirable doses using distilled water. dose used in this study 2 mcg/kg

Eligibility

Inclusion criteria

Inclusion criteria: Children aged 2-8 yrs belonging to ASA physical status I or II scheduled for elective surgery

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
satisfactory sedation score achieved at the time of inductionTimepoint: 45 mins after administration of drug	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactArcojit Ghosh

R G Kar Medical College & Hospital Kolkata

dr.askd@gmail.com9733050609

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026